C41h41n5o8 ANOOSIN, N-Benzoyl-5'-O- Ow (4-Methodyphyl) Phenylmthyl] - 2 -2'-

Canonesch Laachen O = C (NC1 = NC2 = C1N = CN2C3C (CC = 4C = CC = CC4) C = CCA = CC = CC = CC = CC = CC = CC = OCC = CC = CC = CC = CCONEAKT LAILES O = CC1 = C1N = CN2C3C (CC = CC = CC = CC4) C6 = CCA = CC1 = CC1 = CC = CC = CC = CC1
Isomeresch Laachen
C (oc [c @ h] 1o [cc = cc = c @ h] (cmcoc) (c6 = cc = cc = 3c = 3c = 3c = N / NC = CC = C4) N = CN3) (CC = C @
= C6) C7 = CC = CC = C7
Inchi
Inchi = 1s / c41h4n5o8 / C1-49-23-52-36-35 (470.00) 24-53 (360.00 36003333333338 (34-25-38 (34) 46) 41(28-12-8-5-9-13-28,29-14-18-31(50-2)19-15-29)30-16-20-32(51-3)21-17-30/h4-21,25-26,33,35-36,40,47H,22-24H2,1-3H3, (H,42,43,45,48)/t33-,35-,36-,40-/m1/s1
Inchi Schlëssel
KevmxgndTKPSMC-mumpvvmasa-n
16 aner Nimm fir dës Substanz
N-bozoyl-5'-o- [4-contorycyphonel) Phenylylyl] -2' -2'-O- (2-Methoctylyl) ACOOsin); Aoner 17: Pn: US20030211606 Page: 19 verdeedegt Sequenz; 18: Fir 12.00040040005569 Säit: 22 fuerdere Sequenz; 20: Pn: US20040006030 Page: 23 behaapt Sequenz; 20: Pn: US200400140447 Page: 21 verdeedegt Sequenz; 20: Pn: US200400144049 Säit: 21 verdeedegt Sequenz; 21: PN: US20040005570 Pag

E: 20 behaapt Sequenz; 21: PN: US200400144048 Säit: 21 verdeedegte Sequenz; 21: PN: US20040014050 Page: 20 behaapt Sequenz; 22: D'US2004000556565 Page: 17- 22 verdeedegt Sequenz; 22: pn: US2004001140516 Page: 23 behaapt Sequenz; 23: PN: US20040 014699 Page: 20 behaapt Sequenz; 24: D'US2004000029 Säit: 23 Verwaltung ass et geleet ginn. 24: Pn: Wo0336645 Page: 73 behaapt Sequenz; 5'-Dimethoxytatity-2'-O- (2-Mountyl) -N6-bozyl Anoosin; 95: PN: US20040005707 Säit: 20 behaapt Sequenz